Mining the complement system for lupus biomarkers

Clinical and Applied Immunology Reviews

Volumn 5, Issue 3, 2005, Pages 185-206

  Liu, Chau Ching ^a,b   Danchenko, Natalya ^c   Navratil, Jeannine S ^a,b   Nilson, Sarah E ^a,b   Manzi, Susan ^a,b,c   Ahearn, Joseph M ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Biomarker; C4; Complement; Lupus; SLE; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4D; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9;

AUTOIMMUNE DISEASE; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; GENE ACTIVATION; HUMAN; LABORATORY TEST; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 20444473816     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cair.2005.01.004     Document Type: Review

References (81)

1. J. Schiffenbauer B. Hahn M.H. Weisman L.S. Simon Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus Arthritis Rheum 50 2004 2415-2422
2. Biomarker Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 2001 89-95
3. G.G. Illei E. Tackey L. Lapteva P.E. Lipsky Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability Arthritis Rheum 50 2004 1709-1720
4. G.G. Illei E. Tackey L. Lapteva P.E. Lipsky Biomarkers in systemic lupus erythematosus. II. Markers of disease activity Arthritis Rheum 50 2004 2048-2065
5. P.H. Schur J. Sandson Immunological factors and clinical activity in systemic lupus erythematosus N Engl J Med 278 1968 533-538
6. M.J. Walport Complement and systemic lupus erythematosus Arthritis Res 4 2002 S279-S293
7. C.K. Abrass K.M. Nies J.S. Louie W.A. Border R.J. Glassock Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus Arthritis Rheum 23 1980 273-282
8. J.M. Esdaile M. Abrahamowicz L. Joseph T. MacKenzie Y. Li D. Danoff Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: Why some tests fail Arthritis Rheum 39 1996 370-378
9. T.E. Mollnes H.-J. Haga J.G. Burn E.W. Nielsen A. Sjoholm G. Sturfeldt et al. Complement activation in patients with systemic lupus erythematosus without nephritis Rheumatology 38 1999 933-940
10. C.-C. Liu J.M. Ahearn S. Manzi Complement as a source of biomarkers in systemic lupus erythematosus: Past, present, and future Curr Rheumatol Rep 6 2004 85-88
11. C. Hohan S.K. Datta Lupus. Key pathogenic mechanisms and contributing factors Clin Immunol Immunopathol 77 1996 209-220
12. P.H. Schur Complement and lupus erythematosus Arthritis Rheum 25 1982 793-798
13. P.A. Gatenby The role of complement in the aetiopathogenesis of systemic lupus erythematosus Autoimmunity 11 1991 61-66
14. H. Molina Update on complement in the pathogenesis of systemic lupus erythematosus Curr Opin Rheumatol 14 2002 492-497
15. A.P. Manderson M. Botto M.J. Walport The role of complement in the development of systemic lupus erythematosus Annu Rev Immunol 22 2004 431-456
16. J.S. Navratil J.M. Ahearn Apoptosis and autoimmunity: Complement deficiency and systemic lupus erythematosus Curr Rheumatol Rep 2 2001 32-38
17. M.L. Barilla-LaBarca J.P. Atkinson Rheumatic syndromes associated with complement deficiency Curr Opin Rheumatol 15 2003 55-60
18. M.C. Carroll The role of complement and complement receptors in induction and regulation of immunity Annu Rev Immunol 16 1998 545-568
19. R. Barrington M. Zhang M. Fischer M.C. Carroll The role of complement in inflammation and adaptive immunity Immunol Rev 180 2001 5-15
20. W.D. Rantoff Inherited deficiencies of complement in rheumatic diseases Rheum Dis Clin North Am 22 1996 75-94
21. M.W. Turner The role of mannose-binding lectin in health and disease Mol Immunol 40 2004 423-429
22. J.H. Vaughan T.B. Bayles C.B. Favour The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone (ACTH) therapy in lupus erythematosus disseminatus J Lab Clin Med 37 1951 698-702
23. W. Lloyd P.H. Schur Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE) Medicine 60 1981 208-217
24. R.M. Valentijn H. van Overhagen H.M. Hazevoet J. Hermans A. Cats M.R. Daha et al. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus Arthritis Rheum 28 1985 904-913
25. F.A. Houssiau D. D'Cruz V.G.R.V. Hughes Lupus nephritis: The significance of serological tests at the time of biopsy Clin Exp Rheumatol 9 2003 345-349
26. D.M. Ricker L.A. Hebert R. Rohde D.D. Sedmak E.J. Lewis J.D. Clough et al. Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels Am J Kidney Dis 19 1991 678-685
27. C.-K. Ting K.-H. Hsieh A long term immunological study of childhood onset systemic lupus erythematosus Ann Rheum Dis 51 1992 45-51
28. L. Milis B.A. Pussell V. Timmermans J.A. Charlesworth C.A. Morris The value of complement measurements in the assessment of lupus activity Aust NZ J Med 22 1992 338-344
29. J.S. Cameron M.H. Lessof C.S. Ogg B.D. Williams D.G. Williams Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations, DNA-binding capacity, and precipitating anti-DNA antibody Clin Exp Immunol 25 1976 418-427
30. A.J. Swaak J. Groenwold W. Bronsveld Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus Ann Rheum Dis 45 1986 359-366
31. W.J.W. Morrow D.A. Isenberg A. Todd-Porkropek H.F. Parry M.L. Snaith Useful laboratory measurements in the management of systemic lupus erythematosus Q J Med 202 1982 125-138
32. K.I. Lim K. Muir R.J. Powell Urine neopterin: A new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus Ann Rheum Dis 53 1994 743-748
33. P. Horak V. Scudla Z. Hermanova Z. Pospisil L. Faltynek M. Budikova et al. Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus Clin Rheumatol 20 2001 337-344
34. L.D. Kerr B.R. Adelsberg H. Spiera Complement activation in systemic lupus erythematosus: A marker of inflammation J Rheumatol 13 1986 313-319
35. M.S. Gawryl D.S. Chudwin P.F. Langlois T.F. Lint The terminal complement complex, C5b-9, a marker of disease activity in patients with systemic lupus erythematosus Arthritis Rheum 31 1988 188-195
36. G. Sturfelt L. Jonasson A.G. Sjoholm Sequential studies of complement activation in systemic lupus erythematosus Scand J Rheumatol 14 1985 184-196
37. 2-C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation Clin Immunol Immunopathol 42 1987 239-249
38. G. Senaldi V.A. Makinde D. Vergani D.A. Isenberg Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus Ann Rheum Dis 47 1988 913-917
39. J.P. Buyon J. Tamerius H.M. Belmont S.B. Abramson Assessment of disease activity and impending flare in patients with systemic lupus erythematosus: Comparison of the use of complement split products and conventional measurements of complement Arthritis Rheum 35 1992 1028-1037
40. S. Manzi J.E. Rairie A.B. Carpenter R.H. Kelly S.P. Jagarlapudi S.M. Sereika et al. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity Arthritis Rheum 39 1996 1178-1188
41. Y.Y. Chiu R.M. Nisihara R. Wurzner M. Kirschfink I.J. do Messias-Reason sC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients J Investig Allergy Clin Immunol 8 1998 239-244
42. H.M. Belmont P. Hopkins H.S. Edelson H.B. Kaplan R. Ludewig G. Weissmann et al. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease Arthritis Rheum 29 1986 1085-1089
43. P. Hopkins H.M. Belmont J.P. Buyon M. Philips G. Weissmann S.B. Abramson Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis Arthritis Rheum 31 1988 632-641
44. G. Wild J. Watkins A.M. Ward P. Hughes A. Hume N.R. Rowell C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus Clin Exp Immunol 80 1990 167-170
45. J.M. Porcel J. Ordi A. Castro-Salomo M. Vilardell M.J. Rodrigo T. Gene et al. The value of complement activation products in the assessment of systemic lupus erythematosus flares Clin Immunol Immunopathol 74 1995 283-288
46. L.H. Perrin P.H. Lambert P.A. Miescher Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephtitis J Clin Invest 56 1975 165
47. E. Rother B. Lang R. Coldewey K. Hartung H.H. Peter Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus Clin Rheumatol 12 1993 31-35
48. R.J. Falk M.D. Agustin P. Dalmasso Y. Kim S. Lam A. Michael Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus N Engl J Med 312 1985 1594-1599
49. G. Nagy M. Brozik L. Varga G. Fust M. Kirschfink E. Kiss et al. Usefulness of detection of complement activation products in evaluating SLE activity Lupus 9 2000 19-25
50. R.H. Kelly A.B. Carpenter K.S. Sudol S.P. Jugariapudi S. Manzi Complement C3 fragments in urine: Detection in systemic lupus erythematosus patients by Western Blotting Appl Theor Electrophor 3 1993 265-269
51. V.S. Nagi A. Aggarwal R. Dayal S. Naik R. Misra Complement degradation product C3d in urine: Marker of lupus nephritis J Rheumatol 27 2000 380-383
52. A. Ho S.G. Barr L.S. Magder M. Petri A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus Arthritis Rheum 44 2001 2350-2357
53. T.J. Pekin Jr. N.J. Zvaifler Synovial fluid findings in systemic lupus erythematosus (SLE) Arthritis Rheum 13 1970 777-785
54. G.G. Hunder F.C. McDuffie N.G.G. Hepper Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis Ann Intern Med 76 1972 357-363
55. D.L. Goldenberg G. Leff A.I. Grayzel Pericardial tamponade in systemic lupus erythematosus with absent hemolytic complement activity in pericardial fluid NY State J Med 75 1975 910-912
56. G.G. Hunder B.J. Mullen F.C. McDuffie Complement in pericardial fluid of lupus erythematosus Ann Intern Med 80 1974 453-458
57. L.D. Petz G.C. Sharp N.R. Cooper W.S. Irvin Serum and cerebrospinal fluid complement and serum autoantibodies in systemic lupus erythematosus Medicine 50 1971 259-275
58. G. Sturfelt A.G. Sjoholm Complement components, complement activation, and acute phase response in systemic lupus erythematosus Int Arch Allerg Appl Immunol 75 1984 75-83
59. C.A. Alper F.S. Rosen Studies of the in vivo behavior of human C3 in normal subjects and patients J Clin Invest 46 1967 2021-2034
60. L.G. Hunsicker S. Ruddy C.B. Carpenter P.H. Schur J.P. Merrill H.J. Muller-Eberhard et al. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation N Engl J Med 287 1972 835-840
61. J.A. Charlesworth P.W. Peake J. Golding J.D. Mackie Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus Ann Rheum Dis 48 1989 153-159
62. J.A. Sliwinski N.J. Zvaifler Decreased synthesis of the third component (C3) in hypocomplementemic systemic lupus erythematosus Clin Exp Immunol 11 1972 21-29
63. G. Hauptmann G. Tappeiner J.A. Schifferli Inherited deficiency of the fourth component of human complement Immunodefic Rev 1 1988 3-22
64. K. Hartung M.P. Baur R. Coldwey M. Fricke J.R. Kalden H.J. Lakomek et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study J Clin Invest 90 1992 1341-1351
65. J.M. Moulds N.B. Warner F.C. Arnett Complement component C4A and C4B levels in systemic lupus erythematosus: Quantitation in relation to C4 null status and disease activity J Rheumatol 20 1993 443-447
66. C.A. Tieley D.G. Romans M.C. Crookston Localization of Chido and Rodgers determinants to the C4d fragment of human C4 Nature 276 1978 713-715
67. J.P. Atkinson A.C. Chan D.R. Karp C.C. Killion R. Brown D. Spinella et al. Origin of the fourth component of complement related Chido and Rodgers blood group antigens Complement 5 1988 65-76
68. R.E. Rosenfield Jagathambal Antigenic determinants of C3 and C4 complement components on washed erythrocytes from normal persons Transfusion 18 1977 517-523
69. J. Freedman M. Ho C. Barefoot Red blood cell-bound C3d in selected hospital patients Transfusion 22 1982 515-520
70. G.D. Ross W.J. Yount M.J. Walport J.B. Winfield C.J. Parker C.R. Fuller et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation J Immunol 135 1985 2005-2014
71. S. Manzi J.S. Navratil M.J. Ruffing C.-C. Liu N. Danchenko S.E. Nilson et al. Measurement of erythrocyte C4d and complement receptor 1 in the diagnosis of systemic lupus erythematosus Arthritis Rheum 50 2004 3596-3604
72. C.-C. Liu S. Manzi J.M. Ahearn Reticulocytes bearing C4-derived ligands may serve as "instant messengers" of disease activity in systemic lupus erythematosus Mol Immunol 2004 41 abstract 147
73. J.J. Johnson S. Manzi J.S. Navratil A. Kao S.E. Nilson J.M. Ahearn Platelets are decorated by complement ligands in patients with systemic lupus erythematosus (SLE): An etiologic clue and biomarker for cardiovascular disease Arthritis Rheum 2003 48
74. J.M. Esdaile L. Joseph M. Abrahamowicz D. Danoff A.E. Clarke Routine immunologic tests in systemic lupus erythematosus: Is there a need for more studies? J Rheumatol 23 1996 1891-1896
75. L.D. Kerr B.R. Adelsberg P. Schulman H. Spiera Factor B activation products in patients with systemic lupus erythematosus Arthritis Rheum 32 1989 1406-1413
76. H. Jonsson G. Sturfelt U. Martensson L. Truedsson A.G. Sjoholm Prospective analysis of C1q dissociation and complement activation in patients with systemic lupus erythematosus Clin Exp Rheumatol 13 1995 573-580
77. I. Gunnarsson B. Sundelin M. Heimburger J. Forslid R. van Vollenhoven I. Lundberg et al. Repeated renal biopsy in proliferative lupus nephritis - Predictive role of serum C1q and albuminuria J Rheumatol 29 2002 693-699
78. C.E.H. Siegert M.R. Daha C.M.E.S.T. Tseng I.E.M. Coremans L.A. van Es F.C. Breedveld Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus Ann Rheum Dis 52 1993 851-856
79. I.E.M. Coremans P.E. Spronk H. Bootsma M.R. Daha E.A.M. van der Voort L. Kater et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus Am J Kidney Dis 26 1995 595-601
80. M. Mannik M.H. Wener Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative glomerulonephritis Arthritis Rheum 40 1997 1504-1511
81. G. Moroni M. Trendelenburg N.D. Papa S. Quaglini E. Raschi P. Panzeri et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis Am J Kidney Dis 37 2001 490-498